With the recent launches of Novo Nordisk’s Wegovy pill and Eli Lilly’s Foundayo, the obesity market has started to shift toward oral GLP-1 drugs. While Novo leverages its first-mover advantage with ...

June 2, 2026 • The DOJ says it will abide by a federal court order pausing its anti-weaponization fund. And, six states are holding primaries today. Here are the races to watch.